Fintel reports that on July 24, 2025, B of A Securities downgraded their outlook for Titan America (NYSE:TTAM) from Neutral to Underperform. Analyst Price Forecast Suggests 9.63% Upside As of July 17, ...

Me’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an ...

The sale of 23andMe has been finalized, transforming the once-public genetics company into a nonprofit under the leadership ...

The court-appointed Consumer Privacy Ombudsman (CPO) in the 23andMe bankruptcy last month released a 200-plus-page report ...

After Foley Hoag’s prior updates regarding the chapter 11 bankruptcy cases of 23andMe Holding Co and its affiliated debtors ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...

The new 23andMe says it will be adding additional privacy protections, but there are still concerns at the privacy of customer’s data.

DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

In a letter sent today, Public Citizen urged California Attorney General Rob Bonta to launch an immediate investigation into ...

Titan America SA ("Titan America") (NYSE: TTAM), a leading vertically-integrated producer of cement and building materials with operations across the U.S. East Coast, is scheduled to announce its ...